321 related articles for article (PubMed ID: 12843366)
1. Microbiology. Pods invade infected bladders.
Ferber D
Science; 2003 Jul; 301(5629):31. PubMed ID: 12843366
[No Abstract] [Full Text] [Related]
2. Intracellular bacterial biofilm-like pods in urinary tract infections.
Anderson GG; Palermo JJ; Schilling JD; Roth R; Heuser J; Hultgren SJ
Science; 2003 Jul; 301(5629):105-7. PubMed ID: 12843396
[TBL] [Abstract][Full Text] [Related]
3. Structure and function of Escherichia coli type 1 pili: new insight into the pathogenesis of urinary tract infections.
Schilling JD; Mulvey MA; Hultgren SJ
J Infect Dis; 2001 Mar; 183 Suppl 1():S36-40. PubMed ID: 11171011
[No Abstract] [Full Text] [Related]
4. Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages.
Bokil NJ; Totsika M; Carey AJ; Stacey KJ; Hancock V; Saunders BM; Ravasi T; Ulett GC; Schembri MA; Sweet MJ
Immunobiology; 2011 Nov; 216(11):1164-71. PubMed ID: 21802164
[TBL] [Abstract][Full Text] [Related]
5. Blocking adherence of uropathogenic Escherichia coli isolate to HEP-2 cells and bladder of mice in the presence of antibody against p-fimbriae.
Bidhendi SM; Sattari M; Pourbakhsh SA; Mobarez A; Vandyousefi J; Khaki P; Heidari MH; Kazemnejad A
Biologicals; 2007 Apr; 35(2):99-105. PubMed ID: 16879977
[TBL] [Abstract][Full Text] [Related]
6. Host subversion by formation of intracellular bacterial communities in the urinary tract.
Anderson GG; Martin SM; Hultgren SJ
Microbes Infect; 2004 Oct; 6(12):1094-101. PubMed ID: 15380779
[TBL] [Abstract][Full Text] [Related]
7. Vaccination utilizing the FimCH complex as a strategy to prevent Escherichia coli urinary tract infections.
Langermann S; Ballou WR
J Infect Dis; 2001 Mar; 183 Suppl 1():S84-6. PubMed ID: 11171023
[No Abstract] [Full Text] [Related]
8. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection.
Mulvey MA; Schilling JD; Hultgren SJ
Infect Immun; 2001 Jul; 69(7):4572-9. PubMed ID: 11402001
[TBL] [Abstract][Full Text] [Related]
9. Surface properties of Escherichia coli strains responsible for urinary infections.
Romano Carratelli C; Nuzzo I; Galdiero M
Microbiologica; 1987 Jan; 10(1):55-61. PubMed ID: 2883558
[TBL] [Abstract][Full Text] [Related]
10. Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli.
Langermann S; Möllby R; Burlein JE; Palaszynski SR; Auguste CG; DeFusco A; Strouse R; Schenerman MA; Hultgren SJ; Pinkner JS; Winberg J; Guldevall L; Söderhäll M; Ishikawa K; Normark S; Koenig S
J Infect Dis; 2000 Feb; 181(2):774-8. PubMed ID: 10669375
[TBL] [Abstract][Full Text] [Related]
11. Suckling mouse model of urinary tract infections caused by Escherichia coli.
Kétyi I
Acta Microbiol Acad Sci Hung; 1981; 28(4):393-9. PubMed ID: 6119007
[TBL] [Abstract][Full Text] [Related]
12. Type 1, P and S fimbriae, and afimbrial adhesin I are not essential for uropathogenic Escherichia coli to adhere to and invade bladder epithelial cells.
Miyazaki J; Ba-Thein W; Kumao T; Obata Yasuoka M; Akaza H; Hayshi H
FEMS Immunol Med Microbiol; 2002 Mar; 33(1):23-6. PubMed ID: 11985964
[TBL] [Abstract][Full Text] [Related]
13. Intracellular bacterial communities of uropathogenic Escherichia coli in urinary tract pathogenesis.
Anderson GG; Dodson KW; Hooton TM; Hultgren SJ
Trends Microbiol; 2004 Sep; 12(9):424-30. PubMed ID: 15337164
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of urinary tract infections. Bacterial adherence, bladder defense mechanisms.
Parsons CL
Urol Clin North Am; 1986 Nov; 13(4):563-8. PubMed ID: 2877517
[TBL] [Abstract][Full Text] [Related]
15. Interaction of uropathogenic Escherichia coli with host uroepithelium.
Kau AL; Hunstad DA; Hultgren SJ
Curr Opin Microbiol; 2005 Feb; 8(1):54-9. PubMed ID: 15694857
[TBL] [Abstract][Full Text] [Related]
16. Serum antibody effect on induced bladder infection.
Uehling DT; Constant M
Invest Urol; 1970 Jul; 8(1):62-5. PubMed ID: 4914799
[No Abstract] [Full Text] [Related]
17. Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism.
Schilling JD; Mulvey MA; Vincent CD; Lorenz RG; Hultgren SJ
J Immunol; 2001 Jan; 166(2):1148-55. PubMed ID: 11145696
[TBL] [Abstract][Full Text] [Related]
18. Functional analysis of antigen 43 in uropathogenic Escherichia coli reveals a role in long-term persistence in the urinary tract.
Ulett GC; Valle J; Beloin C; Sherlock O; Ghigo JM; Schembri MA
Infect Immun; 2007 Jul; 75(7):3233-44. PubMed ID: 17420234
[TBL] [Abstract][Full Text] [Related]
19. A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli.
Billips BK; Yaggie RE; Cashy JP; Schaeffer AJ; Klumpp DJ
J Infect Dis; 2009 Jul; 200(2):263-72. PubMed ID: 19522648
[TBL] [Abstract][Full Text] [Related]
20. Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli.
Hultgren SJ; Porter TN; Schaeffer AJ; Duncan JL
Infect Immun; 1985 Nov; 50(2):370-7. PubMed ID: 2865209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
